Transaktionen gefunden für: Healthcare
-
Clearwater Berater
Adviser to Carl Zeiss AG on securing a revolving credit facility
Erfahren Sie mehr -
Clearwater Berater
Adviser to Foreman Capital on the sale of Permadental to Modern
Erfahren Sie mehr -
Clearwater Berater
Adviser to Aarhus Dyrehospital on its sale to Djursjukhusgruppen
Erfahren Sie mehr -
Clearwater Berater
Adviser to Unilever Ventures Limited on its sale of BAC BV to Life Technologies Corporation
-
Clearwater Berater
Adviser to Almaviva Santé on its acquisition of two clinics (Aix en Provence and Manosque) from Group Axium
Erfahren Sie mehr -
Clearwater Berater
Adviser to the shareholders of Medinova on its sale to NPM Healthcare
Erfahren Sie mehr -
Clearwater Berater
Adviser to Palex Medical S.A. on raising debt finance from a group of banks
-
Clearwater Berater
Adviser to Getinge Group on its acquisition of Acare Medical Science Ltd
Erfahren Sie mehr -
Clearwater Berater
Adviser to Achmea on the sale of Achmea Vitale to ZorgvandeZaak
Erfahren Sie mehr -
Clearwater Berater
Adviser to Biotest AG on its sale of heipha Dr. Müller GmbH, Biotest Microbiology Corp., Biotest S.à.r.l., Biotest K.K. to Merck KGaA
Erfahren Sie mehr -
Clearwater Berater
Adviser to Between Investeringsgroep on acquiring a 49% stake in Vitea and MetaPlanning
-
Clearwater Berater
Adviser to Between Investeringsgroep on the acquisition of Zorginitiatieven owner of Obesitas
-
Clearwater Berater
Adviser to Medisch Centrum Scheveningen on its sale to Bergman Beauty Clinics
-
Clearwater Berater
Adviser to the shareholders of Excent on its divestment by Waterland Private Equity to De Hoge Dennen and Friesland Bank Investments
Erfahren Sie mehr -
Clearwater Berater
Adviser to Achmea on the divestment of its DFA Service to InVesting
Erfahren Sie mehr -
Clearwater Berater
Adviser to Achmea on the acquisition of a minority stake in Habidrome Wonen
-
Clearwater Berater
Adviser to Achmea on the sale of Argonaut Bemiddeling to Van Dreumel Depiro
-
Clearwater Berater
Adviser to management on the acquisition, together with HgCapital, of Pharma Bio Research